Astaxanthin, Exercise Inflammation, Skin Health
Influence of Astaxanthin Supplementation on Exercise-Induced Inflammation and Skin Health
1 other identifier
interventional
22
1 country
1
Brief Summary
Vigorous exercise can stress the body. Consuming special types of diet supplements may help the body recover better from exercise. This includes a bright red supplement called astaxanthin that is found in certain algae and causes the pink-red color in salmon. Astaxanthin is an antioxidant and may protect cells from damage and improve the way the immune system functions. The main purpose of this study is to determine if 4 weeks of consuming astaxanthin improves recovery from 2.25 hours of intensive running on a treadmill. This study will also measure whether or not astaxanthin supplementation improves skin health
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jan 2022
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 19, 2022
CompletedFirst Submitted
Initial submission to the registry
June 3, 2022
CompletedFirst Posted
Study publicly available on registry
June 8, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 30, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
December 30, 2022
CompletedJune 9, 2023
June 1, 2023
6 months
June 3, 2022
June 8, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Plasma lipid mediators
Plasma concentrations of arachadonic acid oxidized derivatives from LC-MS-MS analysis
Change from pre-study to post-4 weeks supplementation, and immediately post-exercise, and 1.5 hours-, 3 hours-, and 24 hours-post-exerciseingestion to 8- and 24-hours post-ingestion
Secondary Outcomes (2)
Plasma proteins
Change from pre-study to post-4 weeks supplementation, and immediately post-exercise, and 1.5 hours-, 3 hours-, and 24 hours-post-exerciseingestion to 8- and 24-hours post-ingestion
Plasma cytokine panel
Change from pre-study to post-4 weeks supplementation, and immediately post-exercise, and 1.5 hours-, 3 hours-, and 24 hours-post-exerciseingestion to 8- and 24-hours post-ingestion
Study Arms (2)
Astaxanthin
EXPERIMENTALThe astaxanthin capsules will contain 8 mg of astaxanthin from freshwater algae in starch beadlets. Ingested daily for 4 weeks.
Placebo
PLACEBO COMPARATORThe placebo capsules will contain just the starch beadlets with natural red coloring from the pitaya fruit. Ingested daily for 4 weeks.
Interventions
Eligibility Criteria
You may qualify if:
- Male or female, ages 18-57 years.
- Non-smoker.
- Capable of running 2.25 h on laboratory treadmills at 70% VO2max (close to marathon race pace).
- Agree to train normally, maintain weight, and avoid the regular use of large-dose vitamin and mineral supplements, herbs, and medications that influence inflammation and immune function (especially Advil, Motrin, aspirin, and similar anti-inflammatory drugs) for the duration of the 10-week study. (Review supplement and medication use with the Research Manager during orientation).
- Agree to taper exercise training prior to each of the two lab running sessions (as if preparing for a race).
- Willing to avoid astaxanthin supplements (other than what is provided) and natural sources of astaxanthin including algae, yeast, salmon, trout, krill, shrimp and crayfish during the 10-week study.
- Categorized as "low risk" using the American College of Sports Medicine screening questionnaire.
- Generally healthy and without chronic disease including cardiovascular disease (e.g., heart disease, stroke), cancer, type 1 and 2 diabetes, rheumatoid arthritis.
You may not qualify if:
- Inability to comply with study requirements.
- Body weight below 110 pounds.
- Pregnant or breastfeeding.
- Any other concurrent condition which, in the opinion of the primary investigator (PI), would preclude participation in this study or interfere with compliance.
- Current diagnosis of cardiovascular disease, diabetes, or cancer (except for non-melanoma skin cancer).
- History of allergic reactions to astaxanthin.
- Using drugs with 5-alpha-reductase inhibitor (Proscar, Propecia, Avodart, Jalyn).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Appalachian State Universitylead
- LycoRed Ltd.collaborator
Study Sites (1)
Appalachian State University Human Performance Lab, North Carolina Research Campus
Kannapolis, North Carolina, 28081, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
David C Nieman, DrPH
Appalachian State Univ
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Masking Details
- Investigators and study participants will be blind to treatment allocation, with the astaxanthin and placebo supplements contained in identical looking capsules.
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 3, 2022
First Posted
June 8, 2022
Study Start
January 19, 2022
Primary Completion
July 30, 2022
Study Completion
December 30, 2022
Last Updated
June 9, 2023
Record last verified: 2023-06
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF
- Time Frame
- September 2022; indefinitely
- Access Criteria
- Upon request
Will share data upon request.